BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25277182)

  • 1. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.
    Deng J; Liang H; Zhang R; Dong Q; Hou Y; Yu J; Fan D; Hao X
    Oncotarget; 2014 Sep; 5(17):7420-30. PubMed ID: 25277182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.
    Deng J; Liang H; Ying G; Zhang R; Wang B; Yu J; Fan D; Hao X
    Oncotarget; 2014 May; 5(10):3173-83. PubMed ID: 24833402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
    J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.
    Deng J; Liang H; Ying G; Dong Q; Zhang R; Yu J; Fan D; Hao X
    Oncotarget; 2015 Feb; 6(6):4482-95. PubMed ID: 25714013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
    Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
    Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
    Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
    Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
    PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.
    Deng J; Guo J; Guo X; Hou Y; Xie X; Sun C; Zhang R; Yu X; Liang H
    Oncotarget; 2016 Jul; 7(28):43461-43474. PubMed ID: 27223257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylated CpG site count of dapper homolog 1 (DACT1) promoter prediction the poor survival of gastric cancer.
    Deng J; Liang H; Zhang R; Ying G; Xie X; Yu J; Fan D; Hao X
    Am J Cancer Res; 2014; 4(5):518-27. PubMed ID: 25232493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer.
    Xie XM; Deng JY; Hou YC; Cui JL; Wu WP; Ying GG; Dong QP; Hao XS; Liang H
    Cancer Biomark; 2015; 15(3):259-65. PubMed ID: 25769451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma.
    Guo W; Lv P; Liu S; Xu F; Guo Y; Shen S; Liang J; Kuang G; Dong Z
    Mol Carcinog; 2018 Jul; 57(7):854-865. PubMed ID: 29566283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.
    Du Y; Liu Z; Gu L; Zhou J; Zhu BD; Ji J; Deng D
    BMC Cancer; 2012 Jun; 12():249. PubMed ID: 22703336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9 expression and its methylation status in gastric cancer.
    Sun M; Uozaki H; Hino R; Kunita A; Shinozaki A; Ushiku T; Hibiya T; Takeshita K; Isogai M; Takada K; Fukayama M
    Virchows Arch; 2012 Mar; 460(3):271-9. PubMed ID: 22331131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
    Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
    Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
    Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.